PunchNigerian scholar wins research trophy at Manchester UniversityThe Jerusalem PostBritish lord claims Jewish attitudes towards Israel 'undoubtedly' cause of antisemitism - reportCNN TürkPilot Lisans Yönetmeliği'nde değişiklik한겨레정성호 “최민희 징계 안할 순 없지만, 정치력 발휘해야ZDF heuteAktuelle Pressemitteilungen des ZDFSCMP ChinaApec brings world leaders and probably 2 ‘nuclear briefcases’ to Shenzhen매일경제“어제부터 휴대폰 끄고 잠적”…‘리트 만점’ 이진우, 공개검증자리 불참The Sydney Morning HeraldGTA 6 LIVE updates: Consequences for violence, removal of sex workers and stunning gameplay revealed as thirteen-year wait for iconic game ends; reviews say it’s the greatest game ever madeSportstarIndia vs New Zealand, 1st Test Day 1 LIVE score: Play resumes after Lunch; NZ 64/4 (24)ABC NewsCMA Awards 2026: Taylor Swift, Ella Langley, Jessica Chastain and more hit the carpetCBS NewsIran ramps up attacks on Gulf countries after U.S. strikesEl ComercioLima 2027: El pedido urgente del entrenador de la Selección Peruana de Taekwondo Poomsae
The Daily Newsstand · Free, Always
Thursday, November 19, 2026

New study challenges the ‘health benefits’ of turmeric supplements

Translate

People with knee arthritis get little or no pain relief from taking turmeric supplements, according to researchers behind a new review.

Turmeric contains anti-inflammatory compounds known as curcuminoids, which have long been thought to help the most common form of arthritis, osteoarthritis.

The Cochrane review was conducted by an international group of researchers and looked at nine existing studies covering 1,245 people with knee osteoarthritis.

Researchers compared turmeric supplements against a placebo, non-steroidal anti-inflammatory drugs such as ibuprofen and diclofenac, and paracetamol.

The studies examined different turmeric extracts and curcuminoid-based products, which came in different strengths and doses.

Participants were aged 52 to 62 on average, while around two-thirds were women. The studies were conducted in Australia, Belgium, India and Thailand.

Cochrane said the trials were also relatively short, lasting between four weeks and three months.

Taken together, the results showed that – when compared to placebo and anti-inflammatory drugs – turmeric was not more effective.

However, the team said some studies were limited and the available evidence does remain uncertain.

Dr Ivan Shirinsky, lead author of the review and a practising rheumatologist, said: “As a clinician and researcher, I am not surprised by these findings.

“Osteoarthritis is a complex and still incompletely understood disease. Despite intensive research, effective pharmacological treatment options remain limited, and many promising approaches have yielded limited or inconclusive evidence of clinical benefit.

“A better understanding of the mechanisms underlying osteoarthritis may help us develop more effective treatments in the future.

“I would not routinely recommend turmeric supplements to my patients with knee osteoarthritis.

“However, if a patient asked me about them, I would explain what we know and what remains uncertain about their benefits and potential harms, and help them make an informed decision.”

Previous reviews have suggested turmeric may improve pain and physical function in people with osteoarthritis, but Cochrane raised concerns over the trustworthiness of 10 of these clinical trials and excluded them from the final analysis.

Dr Shirinsky said: “This review highlights the importance of assessing the trustworthiness of clinical trials.

“Such assessments help identify studies that require further clarification before their findings can be used to inform conclusions about treatment effects.”

View the original on The Independent →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.